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Objective: To determine the impact of postpolio-syndrome on quality of life in polio sur-
vivors.
Methods: Forty polio survivors were included in the study. Twenty-one patients fulﬁlling
the Halstead’s postpolio-syndrome criteria participated in postpolio-syndrome group. The
remaining nineteen patients formed non-postpolio-syndrome group. Control group was
composed of forty healthy subjects. Quality of life was evaluated by Nottingham Health
Proﬁle, depression by Beck Depression Scale and fatigue by Fatigue Symptom Inventory.
Isometric muscle strength was measured by manual muscle testing.
Results: Total manual muscle testing score was 26.19 ± 13.24 (median: 29) in postpolio-
syndrome group and 30.08 ± 8.9 (median: 32) in non-postpolio-syndrome group. Total
manual muscle testing scores of non-postpolio-syndrome group were signiﬁcantly higher
than that of postpolio-syndrome group. Patients with postpolio-syndrome reported signiﬁ-
cantly higher levels of fatigue and reduced quality of life in terms of physical mobility, pain
and  energy when compared with patients without postpolio-syndrome and control group.It  was not reported a statistically signiﬁcant difference in social and emotional function-
ing and sleep quality between postpolio-syndrome, non-postpolio-syndrome and control
groups. Also it was not found any statistically signiﬁcant difference in Beck Depression
he groups.Scale scores among tPlease cite this article in press as: Garip Y, et al. Health related quality of life in Turkish polio survivors: impact of post-polio on the health
related quality of life in terms of functional status, severity of pain, fatigue, and social, and emotional functioning. Rev Bras Reumatol. 2015.
http://dx.doi.org/10.1016/j.rbre.2014.12.006
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Conclusions: Postpolio-syndrome has a negative impact on quality of life in terms of
functional status, severity of pain and energy. The identiﬁcation, early recognition and reha-
bilitation of postpolio-syndrome patients may result in an improvement in their quality of
life.
©  2015 Elsevier Editora Ltda. All rights reserved.
Qualidade  de  vida  relacionada  com  a  saúde  em  sobreviventes  turcos  da
pólio:  impacto  pós-pólio  na  saúde  relacionada  com  a  qualidade  de  vida
em  termos  de  estado  funcional,  gravidade  da  dor,  fadiga  e  funcionamento
social  e  emocional
Palavras-chave:
Síndrome pós-pólio
Qualidade de vida
Fadiga
Reabilitac¸ão
r  e  s  u  m  o
Objetivo: Determinar o impacto da síndrome pós-pólio na qualidade de vida nos sobre-
viventes da pólio.
Métodos: Quarenta sobreviventes da pólio foram incluídos no estudo. Participaram do grupo
de  síndrome pós-pólio 21 pacientes que atenderam aos critérios de síndrome pós-pólio de
Halstead. Os 19 restantes formaram o grupo não síndrome pós-pólio. O grupo controle foi
composto por 40 indivíduos saudáveis. A qualidade de vida foi avaliada pelo Nottingham
Health Proﬁle, a depressão pela Escala de Depressão de Beck e a fadiga pelo Inventário de
Sintomas de Fadiga. A forc¸a muscular isométrica foi medida por teste muscular manual.
Resultados: O escore total do teste muscular manual foi 26,19 ± 13,24 (mediana: 29) no grupo
de  síndrome pós-pólio e 30,08 ± 8,9 (mediana: 32) no grupo não síndrome pós-pólio. Escores
totais de teste muscular manual de grupo não síndrome pós-pólio foram signiﬁcativamente
maiores do que os do grupo de síndrome pós-pólio. Os pacientes com síndrome pós-pólio
relataram níveis signiﬁcativamente maiores de fadiga e qualidade de vida reduzida em ter-
mos  de mobilidade física, dor e energia quando comparados com pacientes sem síndrome
pós-pólio e grupo controle. Não se relatou uma diferenc¸a estatisticamente signiﬁcativa
no funcionamento social e emocional e na qualidade do sono entre grupos de síndrome
pós-pólio, não síndrome pós-pólio e controle. Além disso, não se encontrou diferenc¸a esta-
tisticamente signiﬁcativa nos escores da Escala de Depressão de Beck entre os grupos.
Conclusões: A síndrome pós-pólio tem um impacto negativo na qualidade de vida em termos
de  estado funcional, gravidade da dor e energia. A identiﬁcac¸ão, o reconhecimento precoce
e  a reabilitac¸ão dos pacientes com síndrome pós-pólio podem resultar em uma melhoria da
qualidade de vida.
© 2015 Elsevier Editora Ltda. Todos os direitos reservados.
of acute poliomyelitis affecting lower limbs; (2) partial orIntroduction
Postpolio-syndrome (PPS) is a neurologic disorder character-
ized by a collection of late manifestations occurring many
years after the initial poliomyelitis infection. New or increased
muscle weakness is the hallmark. The other clinical features
are fatigue, pain in joints, bones and muscles, cold intol-
erance and bulbar symptoms (swallow, speech, respiratory
symptoms). Fatigue has been described as the most common
symptom. PPS symptoms affect the ability to perform the
activities of daily living, mobility, upper limb function, and
respiratory capacity. PPS has a negative effect on quality of
life (QoL).1–3
The present study aimed to investigate QoL in polio sur-
vivors in Turkey, to assess the impact of PPS on various QoLPlease cite this article in press as: Garip Y, et al. Health related quality o
related quality of life in terms of functional status, severity of pain, fatig
http://dx.doi.org/10.1016/j.rbre.2014.12.006
domains in terms of functional status, severity of pain, social
and emotional functioning.Material  and  methods
The study included a total of 40 polio survivors (21 men,
19 women) who were followed at the outpatient clinic of
physical medicine and rehabilitation department of a train-
ing and research Hospital which is a major referral center
under Ministry of Health, located in Ankara, capital city of
Turkey, between December 2012 and September 2013. Study
was conducted in accordance with the principles set forth in
the Helsinki Declaration 2008.
67.5% of polio survivors (21 patients) fulﬁlling the Hal-
stead’s PPS criteria4 participated in PPS group, and the
remaining 19 polio survivors without PPS formed non-PPS
group. Halstead’s PPS criteria are: (1) a conﬁrmed historyf life in Turkish polio survivors: impact of post-polio on the health
ue, and social, and emotional functioning. Rev Bras Reumatol. 2015.
complete neurological and functional recovery after acute
poliomyelitis; (3) new symptoms (extensive fatigue, muscle
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ain and/or joint pain, new muscle weakness in the muscles
reviously affected or unaffected) after a stable period of at
east 15 years; (4) exclusion of other medical conditions that
ay explain these symptoms.4
Isometric muscle strength was measured by manual mus-
le testing (MMT)  according to Medical Research Council (MRC)
cale.5 Hip ﬂexors, knee extensors, knee ﬂexors, ankle dor-
al ﬂexor and ankle plantar ﬂexors were evaluated bilaterally,
hen total score was obtained (maximum score: 50).
Control group consisted of 40 age and sex matched healthy
ubjects (20 men, 20 women) whose total MMT  scores were
0. Inclusion criteria for all subjects were no other disor-
ers including ﬁbromyalgia, hypertension, diabetes mellitus,
epatic and renal diseases, inﬂammatory arthritis, other neu-
ological or psychiatric disorders that may cause fatigue.
Symptoms including muscle pain, fatigue, joint pain, sleep
isorders, respiratory disorders and dysphagia were analyzed
n PPS and non-PPS groups. QoL was assessed by Nottingham
ealth Proﬁle (NHP)6 and depression by using Beck Depression
cale (BDS).7
Fatigue was evaluated by using Turkish version of Fatigue
ymptom Inventory (FSI).8 FSI, ﬁrst published in 1998, is a 14-
tem self-report measure designed to assess fatigue intensity
four items), duration (two items), its interference with quality
f life (7 items), and the daily pattern of fatigue. Intensity is
easured on separate 11-point scales (0 = not at all fatigued;
0 = extreme fatigue) that assess most, least, current fatigue
nd average fatigue in the previous week. Each of these is
cored as an individual item. The interference items assess the
xtent to which fatigue interfered with a respondent’s general
ctivity level, ability to bathe and dress, work activity, ability
o concentrate, relations with others, enjoyment of life and
ood during the previous week using an 11 point rating scale
0 = no interference and 10 = extreme interference). These 7
tems are averaged to obtain an interference scale score. Dura-
ion items (number of days fatigued, amount of time fatigued)
ssess fatigue frequency. It is measured as the number of the
ays (from 0 to 7 days) in the past week that respondents felt
atigued and the amount of each day on average respondents
elt fatigued (0 = none of the day, 10 = the entire day). Each
f these is scored as an individual item. The ﬁnal item asks
espondents to indicate their daily pattern of fatigue and soPlease cite this article in press as: Garip Y, et al. Health related quality o
related quality of life in terms of functional status, severity of pain, fatigu
http://dx.doi.org/10.1016/j.rbre.2014.12.006
rovides descriptive information about possible diurnal vari-
tion in the daily experience of fatigue (0 = not at all fatigued,
 = worse in the morning, 2 = worse in the afternoon, 3 = worse
n the evening, 4 = no consistent daily pattern of fatigue). Final
Table 1 – Demographic and clinical data.
PPS group (n = 2
Age, mean ± SD 38.15 ± 7.17 
Gender (men/women) 11/10 
Age of acute polio (months) 19.85 ± 13.79 
Paralyses of one limb (number of patients) 12 
Paralyses of two limbs (number of patients) 5 
Paralyses of three limbs (number of patients) 2 
Paralyses of four limbs (number of patients) 2 
Total MMT score (0–50), mean ± SD 26.19 ± 13.24 
MMT, manual muscle testing. 5;x  x x(x x):xxx–xxx 3
item provides information only and is not intended to be used
as a quantitative scale.9–11 The items included in the FSI are
shown in Appendix 1.
Statistical  analyses
Data were presented by descriptive analysis with means ±
standard deviation (SD) and median scores. Because vari-
ables were not normally distributed, Kruskal–Wallis and
Mann–Whitney U tests were performed to assess statistically
signiﬁcant differences in MMT, BDS, FSI and NHP scores of
the groups. Categorical variables were evaluated by Chi-square
test. A value of p < 0.05 was considered statistically signiﬁcant.
All analyses were performed using Statistical Package for the
Social Sciences – 13.0 (SPSS-13.0) software.
Results
Demographic and clinical characteristics of the patients and
control subjects are summarized in Table 1. Mean age was
38.15 ± 7.17 in PPS group, 37 ± 4.86 in non-PPS group and
35 ± 8.42 in the control group. At the time of acute polio, polio
survivors were 19.2 ± 12.23 months old on average (3 months
to 4 years, median: 18 months).
Of the patients in PPS group, 12 had paralyses of one limb,
5 had paralyses of two limbs, 2 had paralyses of three limbs,
and 2 had paralyses of four limbs. One of them reported that
the disease affected the respiratory system. Of the patients in
non-PPS group, 15 had paralyses of one limb, 3 had paralyses
of two limbs, and 1 had paralyses of three limbs. None of them
had paralyses of four limbs. Also none of them reported that
the respiratory system was affected (Table 1).
The most common symptoms were fatigue (16 patients,
76.2%), and muscle pain (15 patients, 71.4%) in PPS group.
These were followed by sleep disorders (12 patients, 57.14%)
and joint pain (11 patients, 52.38%), respectively. Dysphagia
and respiratory disorders were noted in one patient (4.76%).
In non-PPS group, the most frequent symptoms were mus-
cle pain, fatigue, sleep disorders and joint pain, which were
reported in 42.1%, 36.8%, 31.58%, 15.79% of the patients,f life in Turkish polio survivors: impact of post-polio on the health
e, and social, and emotional functioning. Rev Bras Reumatol. 2015.
respectively. Fatigue, joint pain and muscle pain were signif-
icantly higher in PPS group (p < 0.05). Total MMT  score was
26.19 ± 13.24 (median: 29) in PPS group and 30.08 ± 8.9 (median:
32) in non-PPS group. According to the Mann–Whitney U test,
1) Non-PPS group (n = 19) Control group (n = 40)
37 ± 4.86 35 ± 8.42
13/6 20/20
17.84 ± 8.45
15
3
1
0
30.08 ± 8.9
ARTICLE IN PRESSRBRE-189; No. of Pages 7
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Table 2 – Comparison of total MMT  scores and symptoms between the PPS and non-PPS groups.
PPS group (n = 21) Non-PPS group (n = 19) p value
Total MMT score (0–50), mean ± SD/median 26.19 ± 13.24/29 30.08 ± 8.9/32 0.04*
Presence of muscle pain, n (%) 15 (71.4%) 8 (42.1%) 0.04*
Presence of fatigue, n (%) 16 (76.2%) 7 (36.8%) 0.01*
Presence of joint pain, n (%) 11 (52.38%) 3 (15.79%) 0.022*
Presence of sleep disorders, n (%) 12 (57.14%) 6 (31.58%) 0.125
Presence of respiratory disorders, n (%) 1 (4.76%) 0 0.48
Presence of dysphagia, n (%) 1 (4.76%) 0 0.48
MMT, manual muscle testing.
∗ p < 0.05 (signiﬁcant).
total MMT  scores of non-PPS group were signiﬁcantly higher
than that of PPS group (p < 0.05) (Table 2).
Kruskal–Wallis test revealed that differences among groups
were signiﬁcant in all FSI subgroups (p < 0.05). According to the
Mann–Whitney U test, FSI scores of PPS group were signiﬁ-
cantly higher than that of both non-PPS group and the control
group (p < 0.05) (Table 3). It was not found any statistically sig-
niﬁcant difference in BDS scores between PPS, non-PPS and
control groups (p > 0.05). Median values of BDS and FSI in
patients and the control group are given in Table 3.
Kruskal–Wallis test showed that differences among groups
were signiﬁcant in all NHP subgroups except social isola-
tion, emotional reaction and sleep (p < 0.05). According to
the Mann–Whitney U test, PPS group scored signiﬁcantly
higher in pain, physical mobility and energy subgroups of
NHP than non-PPS and the control group (p < 0.05). It was
not reported a statistically signiﬁcant difference in social
isolation, emotional reaction and sleep subgroups. Also non-
PPS group reported poorer levels in all NHP groups except
social isolation, emotional reaction and sleep subgroups,
when compared to the control group (Table 4). Median val-
ues of NHP scores in patients and the control group are given
in Table 4.
Discussion
The aim of this study was to investigate QoL in polio survivors
in Turkey in order to assess the impact of PPS on QoL in terms
of functional status, severity of pain, social and emotional
functioning.
The results showed that PPS impaired QoL including physi-
cal mobility, pain and energy, but did not affect emotional and
social health. Furthermore it was not found any statistically
signiﬁcant difference in BDS scores between PPS, non-PPS and
control groups. This ﬁnding conﬁrmed that PPS did not have
a negative impact on emotional status. Our results support
the previous studies in the literature. It was reported lower
scores in physical functioning in 38 post-polio patients in the
study of McNaughton et al. where QoL was measured by using
Short Form-36 (SF-36).12 Similarly, Jacob investigated QoL in
101 polio survivors from two post-polio clinics in Israel and
reported low physical scores and normal mental scores includ-
13Please cite this article in press as: Garip Y, et al. Health related quality o
related quality of life in terms of functional status, severity of pain, fatig
http://dx.doi.org/10.1016/j.rbre.2014.12.006
ing emotional and social functioning in post-polio patients.
Tate et al. conﬁrmed that polio survivors did not differ from
the general population in levels of depression.14 By contrast,
Schanke,15 Conrady16 and Hazendonk17 reported that PPSpatients had higher levels of depressive symptoms as com-
pared to control groups. Also On et al. found lower physical,
social and emotional scores in PPS group where QoL was eval-
uated by using NHP.18
Patients with PPS experienced signiﬁcantly higher levels of
fatigue when compared to non-PPS and control group. This
ﬁnding supports the previous studies.18–20 To our knowledge,
this is the ﬁrst study to evaluate fatigue in polio survivors
by using FSI. Fatigue is a complex symptom and it must be
assessed by a multidimensional questionnaire which identi-
ﬁes different aspects of fatigue in detail. FSI deals with various
characteristics of fatigue and its perceived interference with
quality of life in terms of general work activities, ability to
concentrate, and enjoyment of life and mood. Furthermore, it
states daily patterns of Fatigue.10,11 It was suggested as a use-
ful instrument in assessment of fatigue by the reviewers.21 In
previous studies, no signiﬁcant differences were found in total
MMT scores between PPS and non-PPS groups.18,22 Contrarily,
in our study, total MMT scores of PPS group were signiﬁcantly
lower than that of non-PPS group.
In the present study, the most common symptoms were
fatigue (76.2%), and muscle pain (71.4%) in PPS group. This
result is in accordance with other clinical studies. In a study
by Nollet on disability and functional status in Dutch patients
with PPS, 78% of the patients selected fatigue as their major
problem.22 In Conde’s study, the most frequent complaints
were fatigue (87.1%), muscle pain (82.4%), and joint pain
(72%).23 We found that prevalence of fatigue, joint pain and
muscle pain was signiﬁcantly higher in PPS group than non-
PPS group. Prevalence of sleep disorders was similar in both
of the groups. 57% of PPS patients had sleep disorders. In
the study of van Kralingen, prevalence of sleep disorders
was found as 50%.24 Östlund reported that post polio related
fatigue had a negative effect on sleep quality.25 Contrarily, in
our study, fatigue did not inﬂuence NHP sleep scores.
The small sample size deemed our main limitation. It is
due to the exclusion of concomitant medical and psychiatric
diseases that may cause fatigue.
As a conclusion, PPS has a negative impact on QoL in terms
of functional status, severity of pain and energy. Thus, early
recognition and complex rehabilitation in the beginning of PPS
may result in an increase in QoL in polio survivors. Also iden-
tifying postpolio-related fatigue and then reducing it may bef life in Turkish polio survivors: impact of post-polio on the health
ue, and social, and emotional functioning. Rev Bras Reumatol. 2015.
an additional strategy in improving QoL. Since FSI is a multi-
dimensional questionnaire that presents different aspects of
fatigue, it should take place in clinical practice.
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Table 3 – Comparison of fatigue and depression between the groups.
PPS group (n = 21)
Median values
Non-PPS group
(n = 19)
Median values
Control group
(n = 40)
Median values
Chi-square
(Kruskal–Wallis)
p  value X
(Mann–Whitney U)
p  value Y
(Mann–Whitney U)
p  value Z
(Mann–Whitney U)
Beck Depression Scale 16 13 12 5.43 0.125 0.06 0.83
Most fatigue 9 5 3 53.29* 0.00* 0.00* 0.001*
Least fatigue 7 2 0 62.58* 0.00* 0.00* 0.00*
Current fatigue 7 4 2 53.68* 0.00* 0.00* 0.00*
Average fatigue 7 4 2 53.88* 0.00* 0.00* 0.00*
Interference scale 7 3 1 52.29* 0.00* 0.00* 0.002*
Number of days fatigued 7 3 2 52.46* 0.00* 0.00* 0.002*
Amount of time fatigued 8 4 2 57.23* 0.00* 0.00* 0.00*
p value X: p value between PPS and non-PPS group.
p value Y: p value between PPS and control group.
p value Z: p value between non-PPS and control group.
∗ p < 0.05 (signiﬁcant).
Table 4 – Comparison of QoL between the groups.
PPS group (n = 21)
Median values
Non-PPS group
(n = 19)
Median values
Control group
(n = 40)
Median values
Chi-square
(Kruskal–Wallis)
p  value X p value Y p value Z
NHP physical mobility 87.5 50 0.0 54.04* 0.00* 0.00* 0.00*
NHP pain 85.71 42.86 0.0 61.20* 0.00* 0.00* 0.00*
NHP energy 100 50 0.0 31.66* 0.00* 0.00* 0.00*
NHP social isolation 25 25 25 0.55 0.56 0.72 0.55
NHP emotional reaction 37.5 25 25 2.38 0.79 0.10 0.43
NHP sleep 20 20 20 3.03 0.27 0.08 0.76
NHP, Nottingham Health Proﬁle.
p value X: p value between PPS and non-PPS group.
p value Y: p value between PPS and control group.
p value Z: p value between non-PPS and control group.
∗ p < 0.05 (signiﬁcant).
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Appendix  1.  The  Fatigue  Symptom  Inventory
(FSI)
1-Rate your level of fatigue on the day you felt most fatigued during
0          1          2          3          4         5          6          7          8          9
Not at all fatigued                                                                        Extre 
2-Rate your level of fatigue on the day you felt leas t fatig ued during
0          1          2          3          4         5          6          7          8          9
Not at all fatigued                                                                        Extre 
3- Rate your level of fatigue on the averag e during th e last week. 
0          1          2          3          4         5          6          7          8          9
Not at all fatigued                                                                        Extre 
4- Rate your level of fatigue right now.
0          1          2          3          4         5          6          7          8          9
Not at all fatigued                                                                        Extre 
5-Rate how much in the past week, fatigue interfered with your leve
0          1          2          3          4         5          6          7          8          9
No int erference                                                                            Extre
6-Rate how much, in the past week fatigue interfered with your abili
yourself.
0          1          2          3          4         5          6          7          8          9
No int erference                                                                            Extre
7- Rate how much, in the past week fatigue interfered with your no r
both work outside the home and housework).
0          1          2          3          4         5          6          7          8          9
No int erference                                                                            Extre
8-Rate how much, in the past week fatigue interfered with your abili
0          1          2          3          4         5          6          7          8          9
No int erference                                                                            Extre
9- Rate how much, in the past week fatigue interfered with your rela
0          1          2          3          4         5          6          7          8          9
No int erference                                                                            Extre
10- Rate how much, in the past week fatigue interfered with your en
0          1          2          3          4         5          6          7          8          9
No int erference                                                                            Extre
11- Rate how much, in the past week fatigue interfered with your mo 
0          1          2          3          4         5          6          7          8          9
No int erference                                                                            Extre
12-Indicate how many da ys, in the past  week , yo u fe lt fatigued for a 
0          1          2          3          4         5          6          7              days
13- Rate how mu ch of  the  da y, on  av erage,  you felt fatigued in  the
0          1          2          3          4         5          6          7          8          9
None of  the  da y                                                                           The  
14-Indicate which of the following best describes the da ily  pattern o 
week 
0          1          2          3          4         
0 = not at all fatigued,  1 = worse in the morning, 2 = worse in the afternoon,
3 = worse in the evening, 4 = no consistent daily pattern of fatigue.
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